PGP’s Steve Grassa Discusses How Healthcare Reversed Its M&A Dip
How Healthcare Reversed Its M&A Dip
After several years of declining deal activity, middle-market healthcare M&A regained momentum in 2026. What brought buyers back, and how are private equity sponsors deciding which businesses to sell and when?
PGP Managing Director Steve Grassa joined Middle Market Growth, an ACG podcast, to discuss the forces behind the rebound and what healthcare business owners and investors can expect in the year ahead.
In this episode, Steve covers:
- The dealmaking rebound. How healthcare M&A regained momentum amid growing public and regulatory scrutiny.
- Sponsor exits. What private equity firms are weighing as they decide when to bring portfolio companies to market.
- AI in healthcare. How sponsors are thinking about AI across their healthcare investments.
- The outlook ahead. What Steve is watching as buyers, sellers, and sponsors plan for the coming year.
Whether you’re weighing a sale or keeping an eye on the healthcare M&A market, Steve’s perspective on the 2026 rebound and sponsor exit timing offers a sense of what to watch in the year ahead.
You can listen to the full episode here: How Healthcare Reversed Its M&A Drip
Interested in learning more about market insights, valuation trends, and strategic opportunities?
Speak to a Senior BankerLatest Market Updates


Considering a healthcare transaction? Start with a confidential conversation.
"*" indicates required fields



